-- 
Swiss Daybook: Roche Sales, Baer Settlement and Sulzer Orders

-- B y   C o r i n n e   G r e t l e r
-- 
2011-04-14T05:40:30Z

-- http://www.bloomberg.com/news/2011-04-14/swiss-daybook-roche-sales-baer-settlement-and-sulzer-orders.html
Roche Holding AG (ROG) , the world’s
biggest maker of cancer drugs, said first-quarter sales declined
9 percent as the Swiss franc strengthened and revenue from the
Avastin tumor medicine fell.  Sales dropped to 11.1 billion francs ($12.4 billion) from
12.2 billion francs a year earlier, the Basel, Switzerland-based
company said today in a statement. Analysts predicted 11.3
billion francs, the average of 22 estimates compiled by
Bloomberg. Roche doesn’t release quarterly earnings.  WHAT TO WATCH:
*Nestle holds annual general meeting at 2:30 p.m. in Lausanne  EQUITIES:
*Roche Holding AG’s first-quarter sales declined 9 percent to
11.1 billion francs as the Swiss franc strengthened and revenue
from the Avastin tumor medicine fell
* Julius Baer Group Ltd. (BAER)  agreed with German authorities on a one-time payment of 50 million euros to end investigations against
unknown employees
* Sulzer AG (SUN) ’s first-quarter orders rose 12 percent to 918 million
francs
*Sulzer proposes Musetti to board after Summers declines re-election bid; holds annual general meeting at 10 a.m. in
Winterthur
*Schulthess Group AG holds  shareholders’ meeting  at 4:30 p.m.
*Kuehne + Nagel rated new ‘neutral’ at JPMorgan  ECONOMY/POLITICS:
*Credit Suisse ZEW survey at 11:00 a.m.
*BAK Basel holds spring forecast meeting  MARKETS:
*The SMI rose 0.2 percent to close at 6.364.30
*The SPI rose 0.2 percent to close at 5,807.59
*The Stoxx Europe 600 Index rose 0.7 percent to 278.25
*The MSCI Asia-Pacific Index rose 0.2 percent at 7:23 a.m. in
Zurich
*Euro-franc traded at 1.2954 at 7:20 a.m. Zurich time  To contact the reporter on this story: Corinne Gretler in Zurich
at   Cgretler1@bloomberg.net   To contact the editor on this story:
Matthias Wabl in Zurich at 
 mwabl@bloomberg.net  